Artificial Organs Market Size Worth US$ 31.2 Billion by 2028, at a CAGR of 8.5%

According to the latest report by IMARC Group "Artificial Organs Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028", The global artificial organs market size reached US$ 18.9 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 31.2 Billion by 2028, exhibiting a growth rate (CAGR) of 8.5% during 2023-2028.

Artificial organs refer to human-made engineered medical devices that are implanted or integrated into the human body to replace and replicate the functions of a faulty or missing organ. They are generally manufactured using plastic that is seeded with stem cells from the transplant recipient; therefore, the body's immune system does not reject these organs. At present, the unavailability of adequate natural organs for transplantation and the scarcity of organ donors have been major concerns around the world. In addition to this, finding a compatible organ also poses problems for patients. As a result, the demand for replacement/transplant organs is relatively very high as compared to the supply.

Request for a free sample copy of this report: https://www.imarcgroup.com/artificial-organs-market/requestsample

Note: We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.

Artificial Organs Market Trends:

One of the significant factors which are impelling the growth of the artificial organs market is the increasing prevalence of medical conditions such as strokes, diabetes, cardiac diseases, and chronic kidney diseases. This can be accredited to sedentary lifestyles and the rising consumption of fast food across the globe. Moreover, manufacturers are also investing in research and development activities to suffice the requirements of patients. For instance, they are introducing artificial organs which offer enhanced patient comfort. Further, the consistently growing geriatric population is also influencing the demand for artificial organs. Some of the other factors that are strengthening the market growth are increasing healthcare awareness among individuals, growing incidents of accidents and severe injuries, and the rising acceptance of organ transplant procedures worldwide.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global artificial organs market report, along with forecasts at the global and regional level from 2023-2028. Our report has categorized the market based on type.

Breakup by Type:

Artificial Kidney
Artificial Heart
Artificial Pancreas
Cochlear Implants
Others

Market Breakup by Region:

North America (United States, Canada)
Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
Latin America (Brazil, Mexico, Others)
Middle East and Africa

Competitive Landscape with Key Player:

Abiomed Inc.
Edwards Lifesciences Corp
HeartWare International, Inc.
Cochlear Limited
Boston Scientific Corporation.

Ask Analyst for Customization and Browse full report with TOC & List of Figure: https://www.imarcgroup.com/artificial-organs-market

As the novel coronavirus (COVID-19) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the industry behaviours of the consumers globally and our estimates about the latest market trends and forecasts are being done after considering the impact of this pandemic.

If you want latest primary and secondary data (2023-2028) with Cost Module, Business Strategy, Distribution Channel, etc. Click request free sample report, published report will be delivered to you in PDF format via email within 24 to 48 hours of receiving full payment.

Contact US

IMARC Group
30 N Gould St Ste R
Sheridan, WY 82801 USA - Wyoming
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC's information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company's expertise.

This release was published on openPR.